Your urine color reveals important clues about your health. From hydration levels to potential medical issues learn what your ...

The Food and Drug Administration has approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis in adults.

Researchers have found in new research that persistent lymphopenia is the most significant predictor of in-hospital mortality ...

The One Beam allows for a rapid photo-metric analysis of the bilirubin total in the serum (totals of the conjugated and non-conjugated) using a capillary tube as an optical cell. The bilirubin ...

Strong results to date of Vafseo U.S. launch; expect Vafseo Q1 2025 net product revenues of approximately $10-$11 millionCash resources and cash ...

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...

Hepatic Impairment: Reduce the dose by 25% for patients with severe hepatic impairment. Patients with mild hepatic impairment (total bilirubin ? upper limit of normal [ULN] and aspartate ...

On July 30, 2024, Chemomab announced the closing of a private placement that resulted in gross proceeds of approximately $10 million to the company. Existing investors such as OrbiMed and new ...

Biohaven (BHVN) highlighted the success of BHV-1300, its potential first-in-class IgG selective degrader, in achieving rapid and deep ...

We recently compiled a list of the 10 Stocks With At Least $30 Million In Insider Spending Recently. In this article, we are ...